...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Breast care >Update 2010 of the German AGO Recommendations for the Diagnosis and Treatment of Early and Metastatic Breast Cancer - Chapter A: Surgery, Pathology and Prognostic Factors, Adjuvant and Neoadjuvant Therapy, Adjuvant Radiotherapy
【24h】

Update 2010 of the German AGO Recommendations for the Diagnosis and Treatment of Early and Metastatic Breast Cancer - Chapter A: Surgery, Pathology and Prognostic Factors, Adjuvant and Neoadjuvant Therapy, Adjuvant Radiotherapy

机译：德国AGO关于诊断和治疗早期和转移性乳腺癌的建议的2010年更新-A章：手术，病理和预后因素，辅助和新辅助治疗，辅助放疗

获取原文
   

获取外文期刊封面封底 >>

       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

For the last 9 years, the Breast Committee of the German Gynecological Oncology Group (AGO) has published annually updated and evidence-based recommendations for the diagnosis and treatment of early and metastatic breast cancer. By now, these guidelines are well established and widely used by breast cancer specialists in and outside of Germany. The rating of evidence was performed according to the Oxford group proposals of levels of evidence (LoE; www.cebm.net)[1], whilst the AGO recommendations were made according to a well defined scale (AGO +/−; table ​table1).1). In addition, we published a patients’ version of these recommendations in order to provide patients with the same information as their physicians. Here, we report on the 2010 update of the AGO recommendations. The full version of these guidelines is available as a PDF slide file at www.ago-online.de(‘Leitlinien’) [2]. We focus on differences to the 2009 recommendations, i.e. on updated and new recommendations with regard to surgery, pathology and prognostic factors, adjuvant and neoadjuvant therapy, and adjuvant radiotherapy.
机译：在过去的9年中，德国妇科肿瘤学集团（AGO）的乳腺癌委员会发布了每年更新的基于证据的建议，用于早期和转移性乳腺癌的诊断和治疗。到目前为止，这些指南已被完善，并已被德国国内外的乳腺癌专家广泛使用。证据评级是根据牛津集团的证据水平建议书（LoE; www.cebm.net）[1]进行的，而AGO的建议是根据明确定义的量表（AGO +/-;表1 ）.1）。此外，我们发布了这些建议的患者版本，以便为患者提供与其医生相同的信息。在这里，我们报告了AGO建议的2010年更新。可在www.ago-online.de（“ Leitlinien”）[2]上以PDF幻灯片文件的形式获得这些指南的完整版本。我们将重点放在与2009年建议的差异上，即针对手术，病理和预后因素，辅助和新辅助治疗以及辅助放疗的最新建议和新建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号